Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (May 10, 2023) - Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 48-hrs after the live webcast.

      Investor Contact:
      RA-JJCUS-InvestorRel@ITS.JNJ.com

      Media Contact:
      media-relations@its.jnj.com

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.